HK42694A - Purification and characterization of a fibroblast growth factor - Google Patents

Purification and characterization of a fibroblast growth factor

Info

Publication number
HK42694A
HK42694A HK42694A HK42694A HK42694A HK 42694 A HK42694 A HK 42694A HK 42694 A HK42694 A HK 42694A HK 42694 A HK42694 A HK 42694A HK 42694 A HK42694 A HK 42694A
Authority
HK
Hong Kong
Prior art keywords
growth factor
fibroblast growth
brain
followed
acidic
Prior art date
Application number
HK42694A
Other languages
German (de)
English (en)
French (fr)
Inventor
Kenneth A. Thomas, Jr.
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of HK42694A publication Critical patent/HK42694A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/839—Nerves; brain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK42694A 1983-06-17 1994-05-05 Purification and characterization of a fibroblast growth factor HK42694A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/505,553 US4444760A (en) 1983-06-17 1983-06-17 Purification and characterization of a protein fibroblast growth factor

Publications (1)

Publication Number Publication Date
HK42694A true HK42694A (en) 1994-05-13

Family

ID=24010776

Family Applications (1)

Application Number Title Priority Date Filing Date
HK42694A HK42694A (en) 1983-06-17 1994-05-05 Purification and characterization of a fibroblast growth factor

Country Status (7)

Country Link
US (1) US4444760A (en:Method)
EP (1) EP0131150B1 (en:Method)
JP (1) JPS6011424A (en:Method)
CA (1) CA1241639A (en:Method)
CY (1) CY1780A (en:Method)
DE (1) DE3485001D1 (en:Method)
HK (1) HK42694A (en:Method)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5885899A (ja) * 1981-11-16 1983-05-23 Fujirebio Inc アミラ−ゼインヒビタ−およびその製造法
JPS6028999A (ja) * 1983-06-30 1985-02-14 Maruho Kk 細胞増殖促進作用を有するたんぱく質、その組成物と製造方法
US4785079A (en) * 1984-11-09 1988-11-15 The Salk Institute For Biological Studies Isolation of fibroblast growth factor
US5464774A (en) * 1984-03-05 1995-11-07 The Salk Institute For Biological Studies Bovine basic fibroblast growth factor
DE3586355T2 (de) * 1984-11-29 1993-01-14 Univ Minnesota Heilmittel fuer wunden.
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
DE3587801T2 (de) * 1984-12-24 1994-10-20 Merck & Co Inc Zubereitung enthaltend ein saures Fibroblastewachstumfaktor (aFGF).
US5401832A (en) * 1984-12-24 1995-03-28 Merck & Co., Inc. Brain derived and recombinant acidic fibroblast growth factor
IE66689B1 (en) * 1985-09-12 1996-01-24 Scios Nova Inc Recombinant fibroblast growth factors
US5439818A (en) * 1985-09-12 1995-08-08 Scios Nova Inc. DNA encoding human recombinant basic fibroblast growth factor
US5859208A (en) * 1988-07-06 1999-01-12 Fiddes; John C. Human basic fibroblast growth factor analog
US5827826A (en) * 1986-03-03 1998-10-27 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compositions of human endothelial cell growth factor
US5552528A (en) 1986-03-03 1996-09-03 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bovine b-endothelial cell growth factor
DE3750197D1 (de) * 1986-04-22 1994-08-18 Salk Inst For Biological Studi Antagonisten des Fibroblasten-Wachstumsfaktors.
CA1294546C (en) * 1986-04-23 1992-01-21 John S. Sundsmo Wound healing composition containing collagen
NZ220917A (en) * 1986-07-11 1991-05-28 Merck & Co Inc Human and bovine acidic fibroblast growth factor vectors, hosts and compositions
US4902782A (en) * 1986-12-10 1990-02-20 The Salk Institute For Biological Studies Isolation of fibroblast growth factor
FR2613936B1 (fr) * 1987-04-17 1990-03-30 Centre Nat Rech Scient Application des resines constituees par des polymeres fonctionnels comme phase stationnaire en chromatographie d'affinite pour la purification des facteurs de croissance et procede de purification correspondant
US5459250A (en) 1987-06-16 1995-10-17 New York University Truncated mammalian growth factor DNA sequence
US5750659A (en) * 1987-06-16 1998-05-12 New York University Mammalian growth factor
JPH03500529A (ja) * 1987-06-18 1991-02-07 モナシュ ユニバーシティ 増殖因子
NZ226170A (en) * 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US5312911A (en) * 1987-10-22 1994-05-17 Merck & Co., Inc. Cysteine-modified acidic fibroblast growth factor
AU3863689A (en) * 1988-06-22 1990-01-12 Synergen, Inc. Angiogenic potentiating peptides which potentiate angiogenic factors
CA1341050C (en) * 1988-11-04 2000-07-11 Martin E. Schwab Neurite growth regulatory factors
US5250414A (en) * 1988-11-04 1993-10-05 Erziehungsdirektion Of The Canton Zurich Diagnostic methods using neurite growth regulatory factors
AU652537B2 (en) * 1988-11-04 1994-09-01 Erziehungsdirektion Of The Canton Zurich Neurite growth regulatory factors
DE3900198A1 (de) * 1989-01-05 1990-07-12 Merck Patent Gmbh Topisch anwendbare pharmazeutische zubereitung
US7026291B1 (en) 1989-01-31 2006-04-11 The United States Of America As Represented By The Department Of Health And Human Services Epithelial cell specific growth factor, keratinocyte growth factor (KGF)
AU647732B2 (en) 1989-01-31 1994-03-31 Stuart A. Aaronson DNA encoding a growth factor specific for epithelial cells
JP2814529B2 (ja) * 1989-03-16 1998-10-22 味の素株式会社 虚血性脳障害治療薬
US7300791B2 (en) * 1989-05-12 2007-11-27 Genentech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US20030114374A1 (en) * 1989-05-12 2003-06-19 Genentech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
CA2020720A1 (en) * 1989-07-13 1991-01-14 Shigeko Yamazaki Method for the purification of therapeutically active recombinant acidic fibroblast growth factor
US5043431A (en) * 1989-09-11 1991-08-27 Codon Method and apparatus for the production of TGF-β
US5169837A (en) * 1991-03-28 1992-12-08 Allelix Biopharmaceuticals Inc. Isolated osteogenic factor
US5591709A (en) * 1991-08-30 1997-01-07 Life Medical Sciences, Inc. Compositions and methods for treating wounds
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
JPH08501203A (ja) * 1992-06-03 1996-02-13 ケイス・ウエスタン・リザーブ・ユニバーシティー 生理活性物質を連続的に適用するための包帯
US5331095A (en) * 1993-04-12 1994-07-19 Scios Nova Inc. Process for purification of basic fibroblast growth factor
US5800808A (en) * 1994-05-24 1998-09-01 Veda Research And Development Co., Ltd. Copolymer-1 improvements in compositions of copolymers
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
WO1999066797A1 (en) 1998-06-22 1999-12-29 Worden Charles E Enriched platelet wound healant
US7252818B2 (en) * 1998-07-24 2007-08-07 Cardiovascular Biotherapeutics, Inc. Method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
CN100341895C (zh) * 1998-10-08 2007-10-10 张建军 哺乳动物心肌中提取酸性成纤维细胞生长因子样物质的方法
US6897061B1 (en) * 2000-06-16 2005-05-24 Spinal Cord Society Transdifferentiation of glial cells
US7306919B1 (en) 2001-10-31 2007-12-11 Thornthwaite Jerry T Antigen-antibody cancer recognition system
IL162725A0 (en) * 2002-01-14 2005-11-20 Ford Henry Health System Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors
EP1890820A4 (en) * 2005-03-22 2012-04-11 Cascade Medical Entpr Llc SYSTEMS AND METHOD FOR PRODUCING MEMBRANES
AU2007292253A1 (en) * 2006-09-08 2008-03-13 Wyeth Arginine wash in protein purification using affinity chromatography
KR101021197B1 (ko) 2008-04-11 2011-03-11 (주)케어젠 성장인자―미미킹 펩타이드 및 그의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4195017A (en) * 1975-02-25 1980-03-25 Samuel Bogoch Malignin, derived from brain tumor cells, complexes and polypeptides thereof

Also Published As

Publication number Publication date
CA1241639A (en) 1988-09-06
EP0131150A2 (en) 1985-01-16
JPS6011424A (ja) 1985-01-21
CY1780A (en) 1995-10-20
US4444760A (en) 1984-04-24
DE3485001D1 (de) 1991-10-10
EP0131150A3 (en) 1987-07-15
EP0131150B1 (en) 1991-09-04
JPH0430960B2 (en:Method) 1992-05-25

Similar Documents

Publication Publication Date Title
EP0131150B1 (en) Purification and characterization of a fibroblast growth factor
Thomas et al. Purification and characterization of acidic fibroblast growth factor from bovine brain.
Frolik et al. Purification and initial characterization of a type beta transforming growth factor from human placenta.
EP0128849B1 (en) Purified transforming growth factor-beta derived from human platelets and placentas
RUBIN et al. Isolation and partial sequence analysis of rat basic somatomedin
Gospodarowicz et al. Purification in high yield of brain fibroblast growth factor by preparative isoelectric focusing at pH 9.6.
Svendsen et al. Isolation and characterization of the folate-binding protein from cow's milk
Lemmon et al. Purification and partial characterization of bovine pituitary fibroblast growth factor
Brandenburg et al. The effect of a non-peptide interchain crosslink on the reoxidation of reduced insulin
MacManus The purification of a unique calcium-binding protein from Morris hepatoma 5123 tc
MXPA02007871A (es) Proceso para la purificacion de gonadotropina corionica humana (hcg) y gonadotropina corionica humana recombinante purificada mediante este proceso.
JPS5948422A (ja) 新規なポリペプチドおよびその単離および精製方法
EP0227619A2 (en) New protein and its use
Njikam et al. Carbamylation of the chains of hemoglobin S by cyanate in vitro and in vivo
EP0228357B1 (en) Prostate-derived growth factor
JP2568151B2 (ja) アンジオジェニンの単離方法
Yamaoka et al. The purification of an acid‐and heat‐labile transforming growth factor from an avian sarcoma virus‐transformed rat cell line
Forsum et al. Large-scale fractionation of whey protein concentrates
EP0358463A1 (en) Purification of erythropoietin
Olsen et al. Further characterization of human eosinophil peroxidase
US5576301A (en) Low molecular growth potentiating peptides
Nicola [44] Granulocyte colony stimulating factor
Huebers et al. Isolation and characterisation of rat mucosal ferritin
US5171842A (en) Heparin-binding brain mitogens
WO2007085879A1 (en) Compositions containing substances obtained from the blood and other biological fluid of snake : methods for their preparation and their use

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20040604

PE Patent expired